Aprepitant/Fosaprepitant Dimeglumine and Belimumab Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Belimumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: belimumab
Brand name: Benlysta, Benlysta Autoinjector
Synonyms: Belimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Belimumab Vials
- Aprepitant/Fosaprepitant Dimeglumine-Belinostat
- Aprepitant/Fosaprepitant Dimeglumine-Belinostat Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Belladonna
- Aprepitant/Fosaprepitant Dimeglumine-Belladonna alkaloids and phenobarbital
- Aprepitant/Fosaprepitant Dimeglumine-Belladonna and Opium
- Belimumab Intravenous-Apresazide
- Belimumab Intravenous-Apresoline
- Belimumab Intravenous-Apresoline Injection
- Belimumab Intravenous-Apri
- Belimumab Intravenous-Apriso
- Belimumab Intravenous-Aprizio Pak